Abstract:To observe the effects of Dexmedetomidine on inflammatory factors and renal function in elderly patients after hip replacement treatment so as to provide the basis for subsequent surgical medications. Methods A total of 100 cases accepting hip replacement in our hospital from January 2013 to December 2015 were selected and randomly divided into two groups according to the order of admission with 50 cases in each group. The patients in the experimental group were given 4 μg/ml intravenous infusion of Dexmedetomidine, after 10 min maintained by 0.2 μg/(kg·h) Dexmedetomidine + Midazolam + Propofol; those in the control group were given intravenous injection of 0.9% sodium chloride solution + Midazolam + Propofol. Heart rate (HR), mean arterial pressure (MAP), oxygen saturation (SpO2), serum concentrations of tumor necrosis factor (TNF-α), C-reactive protein(CRP), creatinine (Cr) and urea nitrogen (BUN); the serum and urine levels of kidney injury molecule-1 (KIM-1),and neutrophil gelatinase associated lipocalin (NGAL) were determined before anesthesia, before and after operation and compared. The amount of Propofol and waking time were recorded, and the incidence of adverse reactions wereobserved. At the same time, the Visual Analogue Scoring System (VAS) was used to score the degree of pain after waking and 1 h after operation. The incidences of adverse reactions were observed. Results There was no significant difference in MAP, HR, SpO2, TNF-α, CRP or IL-18 between the two groups before and during surgery ( p> 0.05);postoperative MAP and HR were not significantly different ( p> 0.05). The intraoperative and postoperative expressions of inflammatory factors in the experimental group were lower than those in the control group, and the differences were statistically significant (p < 0.05). There was no statistical difference in the level of Cr or BUN, the serum and urine NGAL or KIM-1, or MMSE score before operation between the two groups (p > 0.05). The serum levels of Cr, BUN, the serum and urine levels of NGAL and KIM-1 before and after operation significantly decreased in the experimental group compared to the control group, which became more obvious with time ( p< 0.05). The Propofol dosage and the incidences of adverse reactions in the experimental group were lower than those in the the control group, the awaking time in the experimental group was shorter than that in the control group, the differences were statistically significant (p < 0.05). The postoperative MMSE score of the experimental group was significantly higher than that of the control group ( p< 0.05). Conclusions Dexmedetomidine not only has a good therapeutic effect on inflammatory factors for elderly hip replacement, but also has a protective effect on the kidneys and low incidences of adverse reactions.